1. Home
  2. CASH vs WVE Comparison

CASH vs WVE Comparison

Compare CASH & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASH
  • WVE
  • Stock Information
  • Founded
  • CASH 1954
  • WVE 2012
  • Country
  • CASH United States
  • WVE Singapore
  • Employees
  • CASH N/A
  • WVE N/A
  • Industry
  • CASH Major Banks
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASH Finance
  • WVE Health Care
  • Exchange
  • CASH Nasdaq
  • WVE Nasdaq
  • Market Cap
  • CASH 1.8B
  • WVE 2.1B
  • IPO Year
  • CASH N/A
  • WVE 2015
  • Fundamental
  • Price
  • CASH $77.74
  • WVE $10.99
  • Analyst Decision
  • CASH Hold
  • WVE Strong Buy
  • Analyst Count
  • CASH 3
  • WVE 10
  • Target Price
  • CASH $80.67
  • WVE $21.60
  • AVG Volume (30 Days)
  • CASH 206.9K
  • WVE 1.0M
  • Earning Date
  • CASH 01-21-2025
  • WVE 03-05-2025
  • Dividend Yield
  • CASH 0.26%
  • WVE N/A
  • EPS Growth
  • CASH 10.58
  • WVE N/A
  • EPS
  • CASH 6.62
  • WVE N/A
  • Revenue
  • CASH $711,045,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • CASH N/A
  • WVE N/A
  • Revenue Next Year
  • CASH $5.10
  • WVE $48.58
  • P/E Ratio
  • CASH $11.74
  • WVE N/A
  • Revenue Growth
  • CASH 10.44
  • WVE N/A
  • 52 Week Low
  • CASH $46.68
  • WVE $3.50
  • 52 Week High
  • CASH $86.00
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • CASH 55.51
  • WVE 34.06
  • Support Level
  • CASH $76.39
  • WVE $10.57
  • Resistance Level
  • CASH $77.84
  • WVE $12.03
  • Average True Range (ATR)
  • CASH 1.85
  • WVE 0.69
  • MACD
  • CASH 0.56
  • WVE -0.17
  • Stochastic Oscillator
  • CASH 93.28
  • WVE 12.54

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: